Contact Tirzepatide Script — Editorial Enquiries

Contact

Tirzepatide Script is an independent editorial publication. We welcome:

• Factual corrections to cited claims
• Suggestions for studies we have not covered
• Requests for clarification on editorial methodology
• General enquiries about the site

We do not provide medical advice, clinical consultations, or referrals. Tirzepatide is an FDA-approved prescription medicine. Questions about whether it is appropriate for any individual belong with a licensed medical professional, not with this site.

Use the form below to reach the editorial team. We aim to respond to corrections within five business days.

---

Tirzepatide Script: an independent editorial record of the dual-incretin research literature. Not a clinic, not a vendor, not a source of clinical advice.